Joint Clinical Assessment, JCA

Sintilimab (NSCLC)

Dossier assessment

Indication:

Treatment of non-small cell lung cancer in adults

Project no.: MP-202508
Report type: Joint Clinical Assessment, JCA
Status: Commission work started
Department/Division: Drug Assessment
Topic: Cancer
Note: This Joint Clinical Assessment (JCA) is being conducted in cooperation with the National Institute for value and technology in health (NIHO), Slovakia.
Further background information can be found here: European health technology assessment

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.